Shares of Vor Bio (Nasdaq: NASDAQ:VOR) rose after it reported that its partner, RemeGen (OTCPK:REGMF), met the main goal in a ...

What are the strange white cone structures located in fields and what do they have to do with aviation? Although they’ve been around since the 1930s and widely in use since the 1970s, Very High ...

Vor Biopharma Inc. (VOR) closed the last trading session at $5.39, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose ...

Fintel reports that on October 15, 2025, Baird upgraded their outlook for Vor Biopharma (NasdaqGS:VOR) from Neutral to ...

Vor Biopharma, a cancer cell therapy developer that laid off nearly all of its employees in a wind down of operations last month, has reemerged with new management, an in-licensed lead drug candidate, ...

We can readily understand why investors are attracted to unprofitable companies. Indeed, Vor Biopharma (NASDAQ:VOR) stock is up 116% in the last year, providing strong gains for shareholders.

Vor Bio has handed Dallan Murray a swift return to the workforce. Weeks after being let go by Sarepta Therapeutics, Murray has landed the chief commercial officer post in Vor’s new-look C-suite.

BOCA RATON, Fla. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akron BioProducts, a leading manufacturer of cGMP-compliant technologies for cell and gene therapy, and Vor Bio (Nasdaq: VOR), a clinical-stage ...

CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of ...

Dr. Zuraw led clinical development of telitacicept across MG, Sjögren’s, SLE, and RA at RemeGen, resulting in multiple regulatory approvals in China; brings deep U.S. and global development experience ...